2021, Number 3
Gout as a cardiovascular risk factor
Language: Spanish
References: 12
Page:
PDF size: 339.63 Kb.
ABSTRACT
Introduction: Gout is a chronic inflammatory disease that generally progresses with added hyperuricemia.Objective: To identify the presence of cardiovascular involvement in patients with a confirmed diagnosis of gouty arthropathy.
Methodology: A basic, non-experimental, descriptive, retrospective and mixed-focus research was developed. The universe consisted of 69 patients treated in first-level health care units in the city of Riobamba during the period between January 2019 and January 2021. The sample was made up of a total of 60 patients. A review of the clinical history of the patients was carried out to obtain the necessary information.
Result: Average age of 53.02 years. 35.00% of them presented at least one associated comorbidity, where diabetes mellitus was the most represented (57.14%). with presence of comorbidities. 71.67% of the patients had normal blood uric acid values at the time of diagnosis and 18.33% had some type of kidney damage. 36.67% of the patients with gout also presented cardiovascular disease, where arterial hypertension (59.09%) was the most frequently reported.
Conclusions: Gouty arthropathy is a disease that theoretically generates a high percentage of cardiovascular diseases within of which arterial hypertension and heart failure stand out.
REFERENCES
Solis Cartas U, Bejarano S, Valdés González JL, Aguirre Saimeda GL. Necrosis avascular de la cabeza femoral en un paciente con gota. Rev Cuba Reumatol. 2018 [Acceso 28/05/2021];20(2):e14. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817-59962018000200009&lng=es
Valdés González JL, Valdés González EM, Solis Cartas U, Sigcho Romero SF. Dengue, COVID-19 y gota, una asociación infrecuente. Rev Cubana Reumatol. 2020 [Acceso 30/05/2021];22(4 Extra.):[aprox. 9 p.]. Disponible en: Disponible en: http://revreumatologia.sld.cu/index.php/reumatologia/article/view/871
Chapalbay Parreño IC, Ayala Reinoso PP, Campos Ruiz LF, Orna Brito VH, Martínez Larrarte JP. Adherencia farmacológica en pacientes con enfermedades reumáticas. Rev Cubana Reumatol . 2019 [Acceso 03/06/2021];21(3):e99. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817-59962019000300003&lng=es
Lombas García M, Giral Casielles R, Mateo Suárez M, Moreno Mejías A, Castell Pérez C. Concepto, clasificación, diagnóstico y tratamiento de las artropatías. Rev Cubana Med . 2009 [Acceso 06/06/2021];13(6):[aprox. 8 p.]. Disponible en: Disponible en: http://revmedicina.sld.cu/index.php/med/article/view/368
Vizcaino Luna Y, Bermúdez Marrero WM, Bermúdez Marrero WA, Egües Mesa JL, Cárdenas Domínguez T, Prendes García E. Gout Arthritis. Ten years of follow up. Rev Cubana Reumatol . 2019 [Acceso 02/06/2021];21(3):[aprox. 9 p.]. Disponible en: Disponible en: http://www.revreumatologia.sld.cu/index.php/reumatologia/article/view/717
López-Rocha EG, Hernández-Montoya G, Rodríguez-Pesina AH, Rodríguez-Mireles KA. Desensibilización a alopurinol en paciente con gota tofácea. Rev Alerg Méx. 2018 [Acceso 02/06/2021];65(3):316-20. Disponible en: Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2448-91902018000300236&lng=es
Leal Balón E, Arjona Rodríguez IA, Quiñones Milián IR, Massip Nicot J, Goberna Rocha M, Fernández Massip H. Perfil clínico y terapéutico en insuficiencia cardiaca aguda. Arch Hosp Univ “Gen. Calixto García”. 2020 [Acceso 03/06/2021];8(3):[aprox. 7 p.]. Disponible en: Disponible en: http://revcalixto.sld.cu/index.php/ahcg/article/view/536